2.0
8 Mar 2016
Former employee, more than 5 years
Recommend
CEO approval
Business outlook
Pros
Novel technology, dedicated colleagues. Excellent customer base among the top Pharma companies around the world. Excellent benefits.
Cons
After the takeover by Accelrys, the future development of the SmartLab enterprise platform was abandoned, as well as many of the employees who helped build the ELN business.